Abciximab reduces mortality in diabetics following percutaneous coronary intervention.

Bhatt, D L

Abciximab reduces mortality in diabetics following percutaneous coronary intervention. [electronic resource] - Journal of the American College of Cardiology Mar 2000 - 922-8 p. digital

Publication Type: Journal Article

0735-1097

10.1016/s0735-1097(99)00650-6 doi


Abciximab
Adult
Aged
Angina, Unstable--mortality
Angioplasty, Balloon, Coronary
Antibodies, Monoclonal--adverse effects
Diabetic Angiopathies--mortality
Dose-Response Relationship, Drug
Drug Administration Schedule
Female
Follow-Up Studies
Humans
Immunoglobulin Fab Fragments--adverse effects
Male
Middle Aged
Myocardial Infarction--mortality
Platelet Aggregation Inhibitors--adverse effects
Platelet Glycoprotein GPIIb-IIIa Complex--antagonists & inhibitors
Randomized Controlled Trials as Topic
Recurrence
Risk Factors
Stents
Survival Rate